Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab
Abstract
Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumors, which can be histologically separated by primary location, proliferation rate and differentiation of tumor cells. The therapeutic options and outcome depend on grading, staging and resectability of the tumor. Established treatment options of neuroendocrine tumors (NET) and carcinomas (NEC) are based especially on surgery, tumor specific medical treatments, peptide guided...
Paper Details
Title
Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab
Published Date
May 14, 2019
Journal
Volume
10
Issue
35
Pages
3302 - 3311
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History